BiopharmIQ
Catalyst Calendar
Big Movers™
All Big Movers™
Current Qtr Report
PDUFA Events
PDUFA Calendar
Current PDUFA Report
Company Screener
M&A Activity
Historical M&A Data
M&A Target Ideas
Meeting Calendar
Hedge Funds
Analysts & Portfolios

My WatchlistsMy Notes
Try Pro FreeAlready have an account? Login

Enterprise Value

3.771B

Cash

267.1M

Avg Qtr Burn

-31.58M

Short % of Float

7.52%

Insider Ownership

0.86%

Institutional Own.

-

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Galafold (migalastat) Details
Fabry disease

Approved

Quarterly sales

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AT-GAA (cipaglucosidase alfa co-administered with miglustat) Details
Pompe Disease

Big Mover™

Suspected Mover™

Susp. Mover™

PDUFA

Approval decision

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AT-GTX-501 Details
Batten Disease

Failed

Discontinued

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AT-GTX-502 Details
Batten Disease

Failed

Discontinued

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.